UPDATED. 2025.04.22(화)

UK’s Royal Hound Leads Innovation in the Global Market with Anti-toxin Pharmaceutical Technology

황성수 CP

2024-11-15 09:15:00


British pet pharmaceutical company RoyalHound is introducing a new approach to pet health management through its proprietary Anti-toxin technology. This technology focuses on developing products that are safe for long-term use in pets, with rigorous testing and ongoing research to ensure and enhance product safety.

The core of Anti-toxin technology lies in its carefully formulated ingredients and design, which allow natural absorption and excretion within the pet’s body. Royal Hound has conducted extensive experiments to verify that these ingredients positively contribute to immune function and overall balance in pets. Multiple research stages have been undertaken to assess safety and effectiveness across long-term use and to maintain product stability. These findings provide pet owners with scientifically reliable information on the safety of the product.

RoyalHound has expanded beyond the UK market, entering the global arena in regions such as Asia and North America. The company continues to pursue research and development to provide products that pet owners across various countries can trust. A spokesperson from Royal Hound stated, “Anti-toxin pharmaceutical technology is helping set a standard for pet health and safety globally. We plan to continue our research efforts to support pet welfare and to offer a variety of products for this purpose.”

The supplements utilizing Anti-toxin technology are designed to maintain stability across diverse environments and conditions, supporting pets in coping with various external factors encountered daily. With long-term safety as a primary goal, this technology aids in effective pet health management. Through such research and development efforts, Royal Hound is establishing a new benchmark for pet health care and continues to maintain high safety standards as it conducts ongoing research in the global market.

Royal Hound’s continued research plays an essential role in ensuring the safety and efficacy of products within the pet supplement market, and this research data will serve as valuable reference material for future product development.

황성수 글로벌에픽 기자 hss@globalepic.co.kr
<저작권자 ©GLOBALEPIC 무단 전재 및 재배포 금지>

주식시황

항목 현재가 전일대비
코스피 2,486.64 ▼1.78
코스닥 716.12 ▲0.67
코스피200 328.61 ▼0.70

가상화폐 시세

암호화폐 현재가 기준대비
비트코인 129,554,000 ▲747,000
비트코인캐시 503,000 ▲3,300
이더리움 2,359,000 ▲15,000
이더리움클래식 22,790 ▲160
리플 3,047 ▲16
이오스 916 0
퀀텀 3,093 ▲40
암호화폐 현재가 기준대비
비트코인 129,667,000 ▲766,000
이더리움 2,360,000 ▲16,000
이더리움클래식 22,780 ▲160
메탈 1,204 ▲3
리스크 742 ▲6
리플 3,049 ▲17
에이다 935 ▲11
스팀 207 0
암호화폐 현재가 기준대비
비트코인 129,580,000 ▲700,000
비트코인캐시 503,500 ▲3,800
이더리움 2,360,000 ▲16,000
이더리움클래식 22,810 ▲170
리플 3,048 ▲19
퀀텀 3,085 ▲17
이오타 256 ▲2